Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Clinical utility of next-generation sequencing in the aetiological diagnosis of sensorineural hearing loss in a Childhood Hearing Loss Unit.

Costales M, Diñeiro M, Cifuentes GA, Capín R, Otero A, Viejo-Díaz M, Plasencia A, Núñez F, Gómez JR, Llorente JL, Cadiñanos J, Cabanillas R.

Acta Otorrinolaringol Esp. 2019 Nov 6. pii: S0001-6519(19)30123-2. doi: 10.1016/j.otorri.2019.05.005. [Epub ahead of print] English, Spanish.

PMID:
31706454
2.

Sequencing results from multiple individuals of different ethnicities strongly question the existence of the KCNE1B pseudogene.

Diñeiro M, Cifuentes GA, Capín R, Santiago A, Otero A, Castillo D, Pruneda PC, Ordóñez GR, Cabanillas R, Cadiñanos J.

Eur J Hum Genet. 2019 Sep 16. doi: 10.1038/s41431-019-0502-6. [Epub ahead of print] No abstract available.

PMID:
31527855
3.

The virtual patient as a learning tool: a mixed quantitative qualitative study.

Isaza-Restrepo A, Gómez MT, Cifuentes G, Argüello A.

BMC Med Educ. 2018 Dec 6;18(1):297. doi: 10.1186/s12909-018-1395-8.

4.

Karst Detection Beneath the Pyramid of El Castillo, Chichen Itza, Mexico, by Non-Invasive ERT-3D Methods.

Chávez RE, Tejero-Andrade A, Cifuentes G, Argote-Espino DL, Hernández-Quintero E.

Sci Rep. 2018 Oct 18;8(1):15391. doi: 10.1038/s41598-018-33888-9.

5.

Comprehensive genomic diagnosis of non-syndromic and syndromic hereditary hearing loss in Spanish patients.

Cabanillas R, Diñeiro M, Cifuentes GA, Castillo D, Pruneda PC, Álvarez R, Sánchez-Durán N, Capín R, Plasencia A, Viejo-Díaz M, García-González N, Hernando I, Llorente JL, Repáraz-Andrade A, Torreira-Banzas C, Rosell J, Govea N, Gómez-Martínez JR, Núñez-Batalla F, Garrote JA, Mazón-Gutiérrez Á, Costales M, Isidoro-García M, García-Berrocal B, Ordóñez GR, Cadiñanos J.

BMC Med Genomics. 2018 Jul 9;11(1):58. doi: 10.1186/s12920-018-0375-5.

6.

A novel molecular diagnostics platform for somatic and germline precision oncology.

Cabanillas R, Diñeiro M, Castillo D, Pruneda PC, Penas C, Cifuentes GA, de Vicente Á, Durán NS, Álvarez R, Ordóñez GR, Cadiñanos J.

Mol Genet Genomic Med. 2017 Apr 23;5(4):336-359. doi: 10.1002/mgg3.291. eCollection 2017 Jul.

7.

[Effects of 12 sessions of high intensity intermittent training and nutrition counseling on body fat in obese and overweight participants].

Molina C, Cifuentes G, Martínez C, Mancilla R, Díaz E.

Rev Med Chil. 2016 Oct;144(10):1254-1259. doi: 10.4067/S0034-98872016001000003. Spanish.

8.

Atomic evidence that modification of H-bonds established with amino acids critical for host-cell binding induces sterile immunity against malaria.

Patarroyo ME, Cifuentes G, Piraján C, Moreno-Vranich A, Vanegas M.

Biochem Biophys Res Commun. 2010 Apr 9;394(3):529-35. doi: 10.1016/j.bbrc.2010.03.004. Epub 2010 Mar 4.

PMID:
20206601
9.

Atomic fidelity of subunit-based chemically-synthesized antimalarial vaccine components.

Patarroyo ME, Cifuentes G, Martínez NL, Patarroyo MA.

Prog Biophys Mol Biol. 2010 Jan;102(1):38-44. doi: 10.1016/j.pbiomolbio.2009.10.006. Epub 2009 Dec 2. Review.

PMID:
19961869
10.

Structural characteristics of immunogenic liver-stage antigens derived from P. falciparum malarial proteins.

Cifuentes G, Vanegas M, Martinez NL, Pirajan C, Patarroyo ME.

Biochem Biophys Res Commun. 2009 Jul 10;384(4):455-60. doi: 10.1016/j.bbrc.2009.04.138. Epub 2009 May 5.

PMID:
19422790
11.

Strategies for developing multi-epitope, subunit-based, chemically synthesized anti-malarial vaccines.

Patarroyo ME, Cifuentes G, Bermúdez A, Patarroyo MA.

J Cell Mol Med. 2008 Oct;12(5B):1915-35. doi: 10.1111/j.1582-4934.2008.00174.x. Review.

12.

Intimate molecular interactions of P. falciparum merozoite proteins involved in invasion of red blood cells and their implications for vaccine design.

Rodriguez LE, Curtidor H, Urquiza M, Cifuentes G, Reyes C, Patarroyo ME.

Chem Rev. 2008 Sep;108(9):3656-705. doi: 10.1021/cr068407v. Epub 2008 Aug 19. Review. No abstract available.

PMID:
18710292
13.
14.

High affinity interactions between red blood cell receptors and synthetic Plasmodium thrombospondin-related apical merozoite protein (PTRAMP) peptides.

Calderón JC, Curtidor H, González O, Cifuentes G, Reyes C, Patarroyo ME.

Biochimie. 2008 May;90(5):802-10. Epub 2007 Dec 8.

PMID:
18158923
15.

Structural characterisation of sporozoite components for a multistage, multi-epitope, anti-malarial vaccine.

Patarroyo ME, Cifuentes G, Rodríguez R.

Int J Biochem Cell Biol. 2008;40(3):543-57. Epub 2007 Oct 5.

PMID:
17997122
16.

Identifying merozoite surface protein 4 and merozoite surface protein 7 Plasmodium falciparum protein family members specifically binding to human erythrocytes suggests a new malarial parasite-redundant survival mechanism.

Garcia Y, Puentes A, Curtidor H, Cifuentes G, Reyes C, Barreto J, Moreno A, Patarroyo ME.

J Med Chem. 2007 Nov 15;50(23):5665-75. Epub 2007 Oct 18.

PMID:
17944453
17.

Antibodies induced by Plasmodium falciparum merozoite surface antigen-2-designed pseudopeptides possess neutralizing properties of the in vitro malarial infection.

Lozano JM, Montoya-Fajardo FJ, Hoebeke J, Cifuentes GH, Forero M, Patarroyo ME.

Peptides. 2007 Oct;28(10):1954-65. Epub 2007 Aug 11.

PMID:
17881088
18.

A pre-PEXEL histidine-rich protein II erythrocyte binding peptide as a new way for anti-malarial vaccine development.

Cifuentes G, Patarroyo ME, Reyes C, Córtes J, Patarroyo MA.

Biochem Biophys Res Commun. 2007 Aug 17;360(1):149-55. Epub 2007 Jun 13.

PMID:
17588541
19.

[Clinical and epidemiological characterisation of dengue haemorrhagic fever in Neiva, Colombia, 2004].

Salgado DM, Rodríguez JA, Garzón M, Cifuentes G, Ibarra M, Vega MR, Castro D.

Rev Salud Publica (Bogota). 2007 Jan-Mar;9(1):53-63. Spanish.

20.

Monosaccharides modulate HCV E2 protein-derived peptide biological properties.

Garcia JE, Fierro R, Puentes A, Cortés J, Bermúdez A, Cifuentes G, Vanegas M, Patarroyo ME.

Biochem Biophys Res Commun. 2007 Apr 6;355(2):409-18. Epub 2007 Feb 8.

PMID:
17306766
22.
23.

Targeting the extracellular domain of fibroblast growth factor receptor 3 with human single-chain Fv antibodies inhibits bladder carcinoma cell line proliferation.

Martínez-Torrecuadrada J, Cifuentes G, López-Serra P, Saenz P, Martínez A, Casal JI.

Clin Cancer Res. 2005 Sep 1;11(17):6280-90.

24.

Protective cellular immunity against P. falciparum malaria merozoites is associated with a different P7 and P8 residue orientation in the MHC-peptide-TCR complex.

Patarroyo ME, Salazar LM, Cifuentes G, Lozano JM, Delgado G, Rivera Z, Rosas J, Vargas LE.

Biochimie. 2006 Feb;88(2):219-30. Epub 2005 Aug 18.

PMID:
16126320
25.

Evidence supporting the hypothesis that specifically modifying a malaria peptide to fit into HLA-DRbeta1*03 molecules induces antibody production and protection.

Cifuentes G, Salazar LM, Vargas LE, Parra CA, Vanegas M, Cortes J, Patarroyo ME.

Vaccine. 2005 Feb 18;23(13):1579-87.

PMID:
15694510
26.

Structural modifications enable conserved peptides to fit into MHC molecules thus inducing protection against malaria.

Patarroyo ME, Cifuentes G, Vargas LE, Rosas J.

Chembiochem. 2004 Nov 5;5(11):1588-93. No abstract available.

PMID:
15515079
27.

Orientating peptide residues and increasing the distance between pockets to enable fitting into MHC-TCR complex determine protection against malaria.

Cifuentes G, Espejo F, Vargas LE, Parra C, Vanegas M, Patarroyo ME.

Biochemistry. 2004 Jun 1;43(21):6545-53.

PMID:
15157087
28.

Immunogenicity and protectivity of Plasmodium falciparum EBA-175 peptide and its analog is associated with alpha-helical region shortening and displacement.

Bermúdez A, Cifuentes G, Guzmán F, Salazar LM, Patarroyo ME.

Biol Chem. 2003 Oct-Nov;384(10-11):1443-50.

PMID:
14669987
29.

Distorting malaria peptide backbone structure to enable fitting into MHC class II molecules renders modified peptides immunogenic and protective.

Cifuentes G, Patarroyo ME, Urquiza M, Ramirez LE, Reyes C, Rodriguez R.

J Med Chem. 2003 May 22;46(11):2250-3.

PMID:
12747797
30.

Analysis of a Plasmodium falciparum EBA-175 peptide with high binding capacity to erythrocytes and their analogues using 1H NMR.

Cifuentes G, Guzmán F, Alba MP, Salazar LM, Patarroyo ME.

J Struct Biol. 2003 Feb;141(2):115-21.

PMID:
12615537
31.

Plasmodium falciparum: binding studies of peptide derived from the sporozoite surface protein 2 to Hep G2 cells.

López R, Curtidor H, Urquiza M, Garcia J, Puentes A, Suarez J, Ocampo M, Vera R, Rodriguez LE, Castillo F, Cifuentes G, Patarroyo ME.

J Pept Res. 2001 Oct;58(4):285-92.

PMID:
11606213

Supplemental Content

Loading ...
Support Center